Pre-treatment With Azithromycin to Reduce Immunogenicity to Anti-Tumor Necrosis Factor- α Agents in Patients With Inflammatory Bowel Disease

Conditions:   Inflammatory Bowel Diseases;   Biological Substance; Adverse Effect Interventions:   Drug: Azithromycin Pill;   Other: Placebo Sponsor:   Rambam Health Care Campus Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials